The next board meeting for Regeneron Pharmaceuticals, Inc. is on 08 Sep 2025 for the purpose of Morgan Stanley 23rd Annual Global Healthcare ConferenceSee details
Regeneron Pharmaceuticals, Inc. - REGN - stock price prediction, stock price target, analyst ratings from 25 analysts
Regeneron Pharmaceuticals, Inc. has a share price target of US$ 717, revenue growth forecast of -2.2%, and profit growth estimate of -17.1% for FY25, based on top 25 analyst calls.